home > news > news details

News Article

Please view below details of the selected news article.

 

Breakthrough osteoporosis treatment, Protelos, receives prestigious Frost & Sullivan Award for Innovation
04/08/2005

San Francisco & Paris, March 16th 2005: Frost & Sullivan, the world-renowned consultancy, presented today their 2004 Osteoporosis Therapeutics Industry Innovation & Advancement of the Year Award, to Servier for the development of its new dual acting osteoporosis treatment Protelos® (S12911, strontium ranelate).

Click here to open full article.

 

 

 

 

News Articles

• Show all
• By Symptom
  • Angina
  • Chronic Stable Angina
  • Depression
  • Essential Hypertension
  • Heart Attacks
  • Heart Failure
  • High Blood Pressure
  • Hypertension
  • Non Insulin Dependent Diabetes
  • Osteoporosis
  • Postmenopausal Osteoporosis
  • Stable Coronary Artery Disease
  • Stroke
  • Type 2 Diabetes
• By Brand
  • Coversyl (perindopril)
  • Coversyl Arginine (perindopril)
  • Coversyl Arginine Plus (perindopril/indapamide)
  • Coversyl Plus (perindopril/indapamide)
  • Diamicron MR (gliclazide)
  • Natrilix (indapamide)
  • Natrilix SR (indapamide)
  • Procoralan (ivabradine)
  • Protelos (strontium ranelate)
  • Valdoxan (agomelatine)